Activated PPARγ enables ERBB2-positive breast cancer cells that produce high levels of fat to convert fatty acids into triglycerides, allowing these cells to avoid cell death caused by lipotoxicity (Kourtidis et al., 2009). Here, ERBB2 is linked to breast carcinoma.